CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine

Vaccine

Volumn 28, Issue 47, 2010, Pages 7514-7522

  Cao, Jun ^a   Wang, Xinglong ^a   Du, Yijun ^a   Li, Yufeng ^a   Wang, Xianwei ^a   Jiang, Ping ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

GP3; GP5; Immune responses; PRRSV

Indexed keywords

ADENOVIRUS VECTOR; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIGEN; RECOMBINANT CD40; RECOMBINANT GLYCOPROTEIN CD40 GP3 GP5; RECOMBINANT GLYCOPROTEIN GP3 GP5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VIREMIA; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD40 LIGAND; CELL LINE; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 77958190167     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.002     Document Type: Article

References (52)

1. Meulenberg J.J., Petersen-den Besten A., De Kluyver E.P., Moormann R.J., Schaaper W.M., Wensvoort G. Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology 1995, 206(1):155-163.
2. Murtaugh M.P., Elam M.R., Kakach L.T. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch Virol 1995, 140(8):1451-1460.
3. Yang L., Frey M.L., Yoon K.J., Zimmerman J.J., Platt K.B. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch Virol 2000, 145(8):1599-1619.
4. Jiang W., Jiang P., Wang X., Li Y., Du Y. Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. Virus Res 2008, 136(1-2):50-57.
5. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Wang C., et al. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS One 2007, 2(6):e526.
6. Tong G., Zhou Y., Hao X., Tian Z., An T., Qiu H. Highly pathogenic porcine reproductive and respiratory syndrome, China. Emerg Infect Dis 2007, 13(9):1434-1436.
7. Zhou Y., Hao X., Tian Z., Tong G., Yoo D., An T., et al. Highly virulent porcine reproductive and respiratory syndrome virus emerged in China. Transbound Emerg Dis 2008, 55(3):152-164.
8. Li Y., Wang X., Jiang P., Chen W. Genetic analysis of two porcine reproductive and respiratory syndrome viruses with different virulence isolated in China. Arch Virol 2008, 153(10):1877-1884.
9. Tian Z.J., An T.Q., Zhou Y.J., Peng J.M., Hu S.P., Wei T.C., et al. An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS. Vet Microbiol 2009, 138(1-2):34-40.
10. Li W., Liu H., Yang X., Zheng J., Wang Y., Si L. Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model. Acta Biochim Biophys Sinica 2009, 41(2):137-145.
11. Jiang Y., Fang L., Xiao S., Li B., Pan Y., Luo R., et al. A suicidal DNA vaccine co-expressing two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus antigens induce protective responses. Biotechnol Lett 2009, 31(4):509-518.
12. Bodmer J.L., Schneider P., Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002, 27(1):19-26.
13. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104(4):487-501.
14. Gares S.L., Fischer K.P., Congly S.E., Lacoste S., Addison W.R., Tyrrell D.L., et al. Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks. Clin Vaccine Immunol 2006, 13(8):958-965.
15. Klaus G.G., Choi M.S., Lam E.W., Johnson-Leger C., Cliff J. CD40: a pivotal receptor in the determination of life/death decisions in B lymphocytes. Int Rev Immunol 1997, 15(1-2):5-31.
16. Higuchi T., Aiba Y., Nomura T., Matsuda J., Mochida K., Suzuki M., et al. Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 2002, 168(1):9-12.
17. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391(6667):591-594.
18. Danese S., de la Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003, 124(5):1249-1264.
19. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M., et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992, 357(6373):80-82.
20. Garside P., Ingulli E., Merica R.R., Johnson J.G., Noelle R.J., Jenkins M.K. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998, 281(5373):96-99.
21. Fanslow W., Srinivasan S., Paxton R., Gibson M., Spriggs M., Armitage R. Structural characteristics of CD40 ligand that determine biological function. Semin Immuno 1994, 6(5):267-278.
22. Graf D., Muller S., Korthauer U., Kooten C., Weise C., Kroczek R. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. European Journal of Immunology 1995, 25(6):1749-1754.
23. Pullen S.S., Labadia M.E., Ingraham R.H., McWhirter S.M., Everdeen D.S., Alber T., et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 1999, 38(31):10168-10177.
24. Huang H.I., Wu P.Y., Teo C.Y., Chen M.N., Chen Y.C., Silin D., et al. Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand. Int J Cancer 2004, 108(5):696-703.
25. Liu J., Yu Q., Stone G.W., Yue F.Y., Ngai N., Jones R.B., et al. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals. Vaccine 2008, 26(32):4062-4072.
26. Gomez C.E., Najera J.L., Sanchez R., Jimenez V., Esteban M. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens. Vaccine 2009, 27(24):3165-3174.
27. Li Y., Wang X., Bo K., Tang B., Yang B., Jiang W., et al. Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet J 2007, 174(3):577-584.
28. Robertson B.H., Grubman M.J., Weddell G.N., Moore D.M., Welsh J.D., Fischer T., et al. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol 1985, 54(3):651-660.
29. Groot Bramel-Verheije M.H., Rottier P.J., Meulenberg J.J. Expression of a foreign epitope by porcine reproductive and respiratory syndrome virus. Virology 2000, 278(2):380-389.
30. Jiang W., Jiang P., Li Y., Tang J., Wang X., Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet Immunol Immunopathol 2006, 113(1-2):169-180.
31. Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., et al. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol 2005, 106(3-4):309-319.
32. Shen G., Jin N., Ma M., Jin K., Zheng M., Zhuang T., et al. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 2007, 25(21):4193-4202.
33. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Zuckermann F., et al. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 2004, 22(3-4):467-474.
34. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Osorio F.A. Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 2002, 21(1-2):21-29.
35. Li J., Jiang P., Li Y., Wang X., Cao J., Zeshan B. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs. Vaccine 2009, 27(6):825-832.
36. Wang X., Li J., Jiang P., Li Y., Zeshan B., Cao J. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge. Virus Research 2009, 143(1):24-32.
37. Plagemann P.G. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2004, 102(3):263-275.
38. Jiang W., Jiang P., Li Y., Wang X., Du Y. Analysis of immunogenicity of minor envelope protein GP3 of porcine reproductive and respiratory syndrome virus in mice. Virus Genes 2007, 35(3):695-704.
39. Pirzadeh B., Dea S. Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J Gen Virol 1998 May, 79(Pt 5):989-999.
40. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 1997, 159(9):4620-4627.
41. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996, 184(2):747-752.
42. Borrow P., Tishon A., Lee S., Xu J., Grewal I., Oldstone M., et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 1996, 183(5):2129-2142.
43. Oxenius A., Campbell K., Maliszewski C., Kishimoto T., Kikutani H., Hengartner H., et al. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J Exp Med 1996, 183(5):2209-2218.
44. Yang Y., Su Q., Grewal I., Schilz R., Flavell R., Wilson J. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996, 70(9):6370-6377.
45. Banchereau J., Blanchard D., Briere F., Liu Y. Molecular control of B-cell immunopoiesis. Annals of the New York Academy of Sciences-Paper Edition 1994, 725:22-33.
46. Van Kooten G., Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Advances in immunology 1996, 61:1-78.
47. Foy T., Laman J., Ledbetter J., Aruffo A., Claassen E., Noelle R. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994, 180(1):157-163.
48. Burdin N., Galibert L., Garrone P., Durand I., Banchereau J., Rousset F. Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes. J Immunol 1996, 156(11):4107-4113.
49. Manoj S., Griebel P.J., Babiuk L.A., van Drunen Littel-van den Hurk S. Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep. J Immunol 2003, 170(2):989-996.
50. Manoj S., Griebel P.J., Babiuk L.A., van Drunen Littel-van den Hurk S. Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154. Immunology 2004, 112(2):328-338.
51. Harcourt J.L., Brown M.P., Anderson L.J., Tripp R.A. CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice. Vaccine 2003, 21(21-22):2964-2979.
52. Stone G.W., Barzee S., Snarsky V., Kee K., Spina C.A., Yu X.F., et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol 2006, 80(4):1762-1772.